Akermin, a St. Louis-based developer of biocatalyst stabilization technology and enzymatic fuel cells, has raised nearly $5 million in Series A-2 funding. Return backers include Prolog Ventures, OnPoint Technologies, Chrysalix Energy,...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)